Ekso Bionics Holdings Stock Performance
| EKSO Stock | USD 8.39 0.11 1.29% |
Ekso Bionics holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.18, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ekso Bionics will likely underperform. Use Ekso Bionics value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on Ekso Bionics.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Ekso Bionics Holdings are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Ekso Bionics displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.91 | Five Day Return 6.25 | Year To Date Return 8.42 | Ten Year Return (99.39) | All Time Return (99.77) |
Last Split Factor 1:15 | Dividend Date 2020-03-25 | Last Split Date 2025-06-02 |
1 | Disposition of 23315 shares by Scott Davis of Ekso Bionics at 4.8 subject to Rule 16b-3 | 11/10/2025 |
2 | How Ekso Bionics Holdings Inc. stock reacts to Fed tightening - Gap Up Daily Profit Maximizing Trade Tips - newser.com | 11/17/2025 |
3 | Disposition of 1238 shares by Jerome Wong of Ekso Bionics at 4.7 subject to Rule 16b-3 | 12/09/2025 |
4 | Can Ekso Bionics Holdings Inc. stock maintain growth trajectory - July 2025 Fed Impact Capital Protection Trade Alerts - | 12/18/2025 |
5 | Applied Digital Splits Cloud Arm, Forms New AI Compute Company With Ekso | 12/30/2025 |
6 | Applied Digital Just Sent Little-Known Ekso Bionics Stock Soaring. Should You Buy Shares Here | 12/31/2025 |
7 | Disposition of 1320 shares by Jason Jones of Ekso Bionics at 9.25 subject to Rule 16b-3 | 01/06/2026 |
8 | Applied Digital beats quarterly revenue estimates on AI data center demand, shares jump | 01/07/2026 |
9 | Applied Digital Posts Strong Q2 As Talks With New Hyperscaler Tenant Advance | 01/09/2026 |
10 | Halper Sadeh LLC Encourages VTYX, SNCY, EKSO Shareholders to Contact the Firm to Discuss Their Rights | 01/13/2026 |
11 | Ekso Bionics Prices 5.852 million Private Placement | 01/21/2026 |
12 | Construction Exoskeleton Market Trends and Supply Chain Analysis 2026-2030 2035 - AI-Driven Exosuits Transforming the Construction Landscape | 01/28/2026 |
| Begin Period Cash Flow | 8.6 M | |
| Total Cashflows From Investing Activities | -37 K |
Ekso Bionics Relative Risk vs. Return Landscape
If you would invest 539.00 in Ekso Bionics Holdings on October 31, 2025 and sell it today you would earn a total of 300.00 from holding Ekso Bionics Holdings or generate 55.66% return on investment over 90 days. Ekso Bionics Holdings is currently generating 1.3576% in daily expected returns and assumes 13.4312% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Ekso, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Ekso Bionics Target Price Odds to finish over Current Price
The tendency of Ekso Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.39 | 90 days | 8.39 | about 8.33 |
Based on a normal probability distribution, the odds of Ekso Bionics to move above the current price in 90 days from now is about 8.33 (This Ekso Bionics Holdings probability density function shows the probability of Ekso Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.18 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ekso Bionics will likely underperform. Moreover Ekso Bionics Holdings has an alpha of 1.2885, implying that it can generate a 1.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Ekso Bionics Price Density |
| Price |
Predictive Modules for Ekso Bionics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ekso Bionics Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ekso Bionics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ekso Bionics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ekso Bionics is not an exception. The market had few large corrections towards the Ekso Bionics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ekso Bionics Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ekso Bionics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.29 | |
β | Beta against Dow Jones | 2.18 | |
σ | Overall volatility | 1.80 | |
Ir | Information ratio | 0.11 |
Ekso Bionics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ekso Bionics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ekso Bionics Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ekso Bionics is way too risky over 90 days horizon | |
| Ekso Bionics appears to be risky and price may revert if volatility continues | |
| Ekso Bionics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 17.93 M. Net Loss for the year was (11.33 M) with profit before overhead, payroll, taxes, and interest of 7.89 M. | |
| Ekso Bionics Holdings currently holds about 31.91 M in cash with (9.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.45. | |
| Ekso Bionics has a frail financial position based on the latest SEC disclosures | |
| Roughly 15.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Construction Exoskeleton Market Trends and Supply Chain Analysis 2026-2030 2035 - AI-Driven Exosuits Transforming the Construction Landscape |
Ekso Bionics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ekso Stock often depends not only on the future outlook of the current and potential Ekso Bionics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ekso Bionics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.2 M | |
| Cash And Short Term Investments | 6.5 M |
Ekso Bionics Fundamentals Growth
Ekso Stock prices reflect investors' perceptions of the future prospects and financial health of Ekso Bionics, and Ekso Bionics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ekso Stock performance.
| Return On Equity | -0.85 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (0.71) % | ||||
| Operating Margin | (0.33) % | ||||
| Current Valuation | 31.66 M | ||||
| Shares Outstanding | 3.56 M | ||||
| Price To Earning | (0.67) X | ||||
| Price To Book | 3.04 X | ||||
| Price To Sales | 2.05 X | ||||
| Revenue | 17.93 M | ||||
| Gross Profit | 7.89 M | ||||
| EBITDA | (9.45 M) | ||||
| Net Income | (11.33 M) | ||||
| Cash And Equivalents | 31.91 M | ||||
| Cash Per Share | 2.45 X | ||||
| Total Debt | 5.98 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 8.16 X | ||||
| Book Value Per Share | 3.69 X | ||||
| Cash Flow From Operations | (9.85 M) | ||||
| Earnings Per Share | (5.38) X | ||||
| Market Capitalization | 30.29 M | ||||
| Total Asset | 26.65 M | ||||
| Retained Earnings | (250.47 M) | ||||
| Working Capital | 11.31 M | ||||
| Current Asset | 17.57 M | ||||
| Current Liabilities | 5.51 M | ||||
About Ekso Bionics Performance
By examining Ekso Bionics' fundamental ratios, stakeholders can obtain critical insights into Ekso Bionics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Ekso Bionics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 178.46 | 118.13 | |
| Return On Tangible Assets | (0.47) | (0.49) | |
| Return On Capital Employed | (0.49) | (0.52) | |
| Return On Assets | (0.38) | (0.40) | |
| Return On Equity | (0.80) | (0.84) |
Things to note about Ekso Bionics Holdings performance evaluation
Checking the ongoing alerts about Ekso Bionics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ekso Bionics Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ekso Bionics is way too risky over 90 days horizon | |
| Ekso Bionics appears to be risky and price may revert if volatility continues | |
| Ekso Bionics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 17.93 M. Net Loss for the year was (11.33 M) with profit before overhead, payroll, taxes, and interest of 7.89 M. | |
| Ekso Bionics Holdings currently holds about 31.91 M in cash with (9.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.45. | |
| Ekso Bionics has a frail financial position based on the latest SEC disclosures | |
| Roughly 15.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Construction Exoskeleton Market Trends and Supply Chain Analysis 2026-2030 2035 - AI-Driven Exosuits Transforming the Construction Landscape |
- Analyzing Ekso Bionics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ekso Bionics' stock is overvalued or undervalued compared to its peers.
- Examining Ekso Bionics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ekso Bionics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ekso Bionics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ekso Bionics' stock. These opinions can provide insight into Ekso Bionics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Will Health Care Equipment & Supplies sector continue expanding? Could Ekso diversify its offerings? Factors like these will boost the valuation of Ekso Bionics. Projected growth potential of Ekso fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ekso Bionics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (5.38) | Revenue Per Share | Quarterly Revenue Growth 0.024 | Return On Assets | Return On Equity |
Investors evaluate Ekso Bionics Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Ekso Bionics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Ekso Bionics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Ekso Bionics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ekso Bionics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Ekso Bionics' market price signifies the transaction level at which participants voluntarily complete trades.